Every Man Jack has been acquired by The Carlyle Group
Every Man Jack has received a majority equity investment from The Carlyle Group.
Every Man Jack is one of the largest independent personal care and grooming brands formulated exclusively for men, with a full range of body, hair, deodorant, beard, shaving and skincare products. Focused on naturally derived and plant-based ingredients, Every Man Jack offers affordable and accessible clean personal care and grooming alternatives, all without compromising on performance. A first mover in the natural category, Every Man Jack sells online and via major retail partners in the mass, natural, grocery and drug channels in the USA and Canada. The investment by The Carlyle Group will help Every Man Jack accelerate its mission to deliver innovative, naturally derived personal care products to an increasing number of consumers and retailers globally.
With 29 offices across five continents and more than 1,800 professionals worldwide, The Carlyle Group leverages its global network to deliver its best thinking and drive positive change.
Oaklins’ team in Los Angeles acted as the exclusive financial advisor to Every Man Jack in this transaction.
Talk to the deal team
Gary S. Rabishaw
Oaklins Intrepid
Steven Davis
Oaklins Intrepid
Related deals
OBI Group has acquired the OBI and individual DIG stores from Migros
As part of a strategic review, Migros has decided to divest its DIY business, which included several “Do It + Garden” and “OBI” locations. Migros had operated the Swiss OBI stores as a franchisee. In OBI Group Holding, Migros has found the ideal partner to ensure continuity for both its customers and employees.
Learn moreDen Berk Délice accelerates growth through strategic partnership
Den Berk Délice, a leading Belgian grower of specialty tomatoes, has entered a strategic partnership with Egeria, an independent investment firm, to realize its next growth phase.
Learn moreXiel Limited has been acquired by MIS Healthcare
MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.
Learn more